Sop Hi A Genetics Sa SOPH
We take great care to ensure that the data presented and summarized in this overview for SOPHiA GENETICS SA is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SOPH
View all-
Ubs Asset Management Americas Inc Chicago, IL7.63MShares$24.7 Million0.01% of portfolio
-
Generation Investment Management LLP London, X06.79MShares$22 Million0.14% of portfolio
-
Chuck Akre Akre Capital Management LLC | Middleburg, Va2.24MShares$7.25 Million0.08% of portfolio
-
Banque Pictet & Cie Sa2.21MShares$7.15 Million0.05% of portfolio
-
Credit Suisse Ag Zurich, V82.17MShares$7.02 Million0.01% of portfolio
-
Alta Wealth Advisors LLC1.41MShares$4.57 Million2.16% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.39MShares$4.49 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny539KShares$1.75 Million0.0% of portfolio
-
Pictet & Cie (Europe) Sa255KShares$826,8480.02% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V8203KShares$658,8020.01% of portfolio
Latest Institutional Activity in SOPH
Top Purchases
Top Sells
About SOPH
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Insider Transactions at SOPH
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|